Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations

Annals of Surgical Oncology

Volumn 20, Issue 3 SUPPL., 2013, Pages

  Bruin, Sjoerd C ^a   De Ronde, Jorma J ^a   Wiering, Bas ^b   Braaf, Linde M ^a   De Wilt, J H W ^b   Vincent, Andrew D ^a   Van Velthuysen, Marie Louise F ^c   Ruers, T J ^a   Wessels, Lodewyk F A ^a,d   Van'T Veer, Laura J ^c,e  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c Department of Pathology ^*  (Netherlands)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA;

ADULT; AGED; ALGORITHM; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME 12P; CHROMOSOME ABERRATION; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; GENE DOSAGE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PREDICTIVE VALUE; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; CANCER STAGING; CHROMOSOME 12; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FOLLOW UP; GENETICS; GENOMICS; LIVER NEOPLASMS; LIVER RESECTION; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SECONDARY;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENOMICS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATIENT SELECTION; PROGNOSIS;

EID: 84892829226     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2985-7     Document Type: Article

References (32)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet. 2005;365(9454):153-65.
2. Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg. 1979;189(4):496-502.
3. Sadahiro S, Suzuki T, Ishikawa K, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of 10 years. Hepatogastroenterology. 2003;50(53): 1362-6.
4. Galandiuk S, Wieand HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1992;174(1):27-32.
5. Penna C, Nordlinger B. Colorectal metastasis (liver and lung). Surg Clin North Am. 2002;82(5):1075-90.
6. Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1,541 necropsies. J Pathol. 1986;150(3):195-203.
7. Neal CP, Garcea G, Doucas H, et al. Molecular prognostic markers in resectable colorectal liver metastases: a systematic review. Eur J Cancer. 2006;42(12):1728-43.
8. Gomez D, Sangha VK, Morris-Stiff G, et al. Outcomes of intensive surveillance after resection of hepatic colorectal metastases. Br J Surg. 2010;97(10):1552-60.
9. Farid SG, Aldouri A, Morris-Stiff G, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251(1):91-100.
10. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247(1):125-35.
11. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100(2):278-84.
12. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg. 1987;205(3):256-63.
13. Lopez P, Marzano E, Piardi T, Pessaux P. Repeat hepatectomy for liver metastases from colorectal primary cancer: a review of the literature. J Visc Surg. 2012;149:97-103.
14. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235(6):863-71.
15. Yan TD, Sim J, Black D, Niu R, Morris DL. Systematic review on safety and efficacy of repeat hepatectomy for recurrent liver metastases from colorectal carcinoma. Ann Surg Oncol. 2007;14(7):2069-77.
16. Welsh FK, Tekkis PP, John TG, Rees M. Predictive models in colorectal liver metastases-can we personalize treatment and outcome? Dig Surg. 2008;25(6):406-12.
17. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg. 1999;230(3):309-18.
18. Kattan MW, Gonen M, Jarnagin WR, et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247(2):282-7.
19. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-67.
20. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50(1):113-30.
21. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer. 1996;15(4):234-45.
22. Meijer GA, Hermsen MA, Baak JP, et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol. 1998;51(12):901-9.
23. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology. 2002;123(4):1109-19.
24. Mekenkamp LJ, Haan JC, Koopman M, et al. Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer. Gut. 2013;62(1):94-101.
25. Wiering B, Ruers TJ, Krabbe PF, Dekker HM, Oyen WJ. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Ann Surg Oncol. 2007;14(2):818-26.
26. Joosse SA, van Beers EH, Nederlof PM. Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material. BMC Cancer. 2007;7:43.
27. van Beers EH, Joosse SA, Ligtenberg MJ, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2006;94(2):333-7.
28. de Ronde JJ, Klijn C, Velds A, et al. KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data. BMC Res Notes. 2010;3:298.
29. Mehta KR, Nakao K, Zuraek MB, et al. Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer. Clin Cancer Res. 2005;11(5):1791-7.
30. Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 2007;23(6):657-63.
31. Uddin S, Ahmed M, Hussain A, et al. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Am J Pathol. 2011;178(2):537-47.
32. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000;36(13 Spec No):1621-30.